Taiwan Liposome Ltd 's ROA from the fourth quarter of 2020 to the fourth quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Taiwan Liposome Ltd 's ROA in the fourth quarter of 2020?
Taiwan Liposome Company Ltd recorded a cumulative net loss of $-35 million during 12 months ending in the fourth quarter of 2020, resulting in a negative return on assets (ROA) of -56.2%.

However, within the Healthcare sector 722 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2020 from to 4808.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2020) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2019) IV. Quarter
Y / Y Total Assets Change	28.19 %	34.45 %	34.45 %	34.45 %	3.31 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-35	-27	-27	-27	-27
Return On Assets (TTM)	-56.2 %	-45.85 %	-49.18 %	-53.04 %	-57.55 %
TLC's Total Ranking	# 4808	#	#	#	# 4857
Total Assets (TTM) in million	62	62	62	62	49
Seq. Total Assets Change	0.06 %	0 %	0 %	28.12 %	4.94 %
Seq. Net Income Change	-	-	-	-	-

TLC's 5 Years Annual ROA >> Back to TLC Management Effectiveness >> Compare TLC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 344
Sector	# 723
Overall	# 4671

Return On Assets Statistics
High	Average	Low
-56.21 %	-57.24 %	-58.26 %
(Dec 31 2020)		(Dec 31 2019)

Financial Statements
Taiwan Liposome Ltd 's Assets	$ 62 million	TLC's Balance sheet
Taiwan Liposome Ltd 's Income	$ -35 million	Quarterly TLC's Income Statement
TLC's Income by Division		See TLC's Income by Division

Annual Return On Assets	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019	(Dec 31 2018) FY 2018	FY	FY
Y / Y Total Assets Change	28.19 %	3.31 %	-	-	-
Total Assets in million	62	49	47	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-35	-27	-29	0	0
Annual Return On Assets	-56.17 %	-55.52 %	-62.57 %	-	-

TLC's 5 Years Annual ROA >> Back to TLC Management Effectiveness >> Compare TLC ROA to its Competitors

More Return On Assets Ratios
TLC's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TLC's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TLC's Competitors
Subscribers only: Roa for Taiwan Liposome Ltd 's Suppliers
Subscribers only: Return On Assets for TLC's Customers

You may also want to know
TLC's Roi	TLC's Inventory Turnover Ratio	TLC's Growth Rates	TLC's Dividend Comparisons
	TLC's Profitability Ratios	TLC's Asset Turnover Ratio	TLC's Dividend Growth
TLC's Roe	TLC's Valuation Ratios	TLC's Financial Strength Ratios	TLC's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2020, within Healthcare Sector

ROA

Date modified: 2026-09-18T13:11:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.